Quality of Life Following Parathyroidectomy for Primary Hyperparathyroidism: Symptom Resolution Kinetics
Clinical Endocrinology · 2026-12 · 105 (6) · 616-622
DOI: 10.1111/cen.70208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, online erschienen am 05.10.2026. Verfasst von Jacquelyn Elise Fitzgerald Speer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Parathyroidectomy, Hyperparathyroidism, Primary, Quality of Life. Die Arbeit nennt 31 Literaturangaben. Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Objective
Primary hyperparathyroidism has been associated with significant symptom burden and impaired quality of life (QoL), yet the trajectory of recovery, especially in reoperative patients is incompletely characterised. This study evaluated longitudinal QoL changes following parathyroidectomy, characterising symptom resolution kinetics and comparing outcomes between cohorts. A prospective longitudinal cohort study was conducted between July 2021 and September 2023 at a single high volume tertiary centre. Patients with biochemically confirmed primary hyperparathyroidism who underwent parathyroidectomy were selected to complete the Primary Hyperparathyroidism Quality of Life questionnaire preoperatively, at 2 weeks postoperatively and then monthly through 12 months postoperative.
Results
There were 124 patients who completed at least one survey. Mean QoL scores improved significantly from baseline (31) to Month 1 (42; Cohen's d = 0.92). Symptom resolution generally occurred in over half of patients, with fatigue and bone pain resolving in 88% and 85% of patients by Month 12 respectively. Neuropsychiatric symptoms had a more variable postoperative resolution. Lower baseline QoL was the only predictor in postoperative QoL score improvement ( β = −0.51, p < 0.01). Reoperative parathyroidectomy was associated with similar QoL improvements but higher rates of persistent neurocognitive symptoms.
Conclusion
Parathyroidectomy results in both rapid and persistent improvement in QoL in patients with primary hyperparathyroidism. Symptom resolution was variable based on number of operations and symptom domain. Baseline QoL was the strongest predictor of benefit supporting the use of QoL as a preoperative metric to be considered in patients with primary hyperparathyroidism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Rachael Caretti
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Speer, J. E. F., Khan, M. O., Wang, R., Caretti, R., Swaminathan, N., Gillis, A., Lindeman, B., Dream, S., & Chen, H. (2026). Quality of Life Following Parathyroidectomy for Primary Hyperparathyroidism: Symptom Resolution Kinetics. Clinical Endocrinology, 105(6), 616-622. https://doi.org/10.1111/cen.70208
Vancouver
Speer JEF, Khan MO, Wang R, Caretti R, Swaminathan N, Gillis A, et al. Quality of Life Following Parathyroidectomy for Primary Hyperparathyroidism: Symptom Resolution Kinetics. Clinical Endocrinology. 2026;105(6):616-622. doi:10.1111/cen.70208
BibTeX
@article{Speer2026,
author = {Speer, Jacquelyn Elise Fitzgerald and Khan, Muhammad Osama and Wang, Rongzhi and Caretti, Rachael and Swaminathan, Niranjna and Gillis, Andrea and Lindeman, Brenessa and Dream, Sophie and Chen, Herbert},
title = {Quality of Life Following Parathyroidectomy for Primary Hyperparathyroidism: Symptom Resolution Kinetics},
journal = {Clinical Endocrinology},
year = {2026},
volume = {105},
number = {6},
pages = {616--622},
doi = {10.1111/cen.70208}
}
EUVIMED